Today is an exciting and transformative day for Jazz Pharmaceuticals as we complete the acquisition of @GW Pharmaceuticals and its U.S. subsidiary, @Greenwich Biosciences, a world leader in the science, development and commercialization of regulatory approved cannabinoid medicines.
Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow that can progress quickly if not treated. Leukemia is the most common cancer in children, and about three out of four of these cases are ALL.
August 1 marks World Lung Cancer Day. Under normal circumstances, this would be an opportunity to raise awareness of a disease that accounts for nearly one in five cancer deaths globally while sharing information about risk factors and highlighting the importance of early detection.
Narcolepsy is still a widely misunderstood and underdiagnosed disorder. Sadly, in children and adolescents, narcolepsy can often be mistaken for laziness or lack of motivation. This means many children living with the life-long condition may experience feelings of loneliness and isolation.
Jazz is implementing a robust continuity plan in response to the COVID-19 pandemic in order to deliver on our mission of providing essential medicines to patients around the world. Our focus at Jazz is to develop life-changing medicines for people with serious diseases — often with limited or no options, and to support our patient communities in their overall wellness.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.